Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
Tamara L. Lotan(Johns Hopkins University), Jeremy A. Squire(Universidade de São Paulo)
Cited by 90
Related Papers
PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
|Clinical Cancer Research|2011|350
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
|PubMed|2022|172
Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related Changes
|Clinical Cancer Research|2006|107
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer
|Modern Pathology|2018|100
Constitutional UPD for chromosome 11p15 in individuals with isolated hemihyperplasia is associated with high tumor risk and occurs following assisted reproductive technologies
|American Journal of Medical Genetics Part A|2006|83